INTEGRIS GROVE HOSPITAL — History
CCN 370113 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$53M
Latest Revenue (FY2022)
+8.5%
Revenue CAGR (3yr)
-16.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $45M | $52M | $53M | +2.5% | +8.5% |
| Operating Expenses | $50M | $58M | $62M | +7.3% | +11.8% |
| Operating Margin | -9.9% | -11.5% | -16.8% | -45.6% | +0.0% |
| Net Income | $-4M | $-6M | $-9M | -49.2% | +0.0% |
| Licensed Beds | 41 | 41 | 41 | +0.0% | +0.0% |
| Total Patient Days | 6,375 | 6,183 | 5,293 | -14.4% | -8.9% |
| Medicare Day % | 41% | 36% | 34% | -6.1% | -8.8% |
| Medicaid Day % | 21% | 24% | 26% | +6.1% | +9.3% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +17.7% ($45M → $53M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.5%
This Hospital
+7.6%
State Avg
Latest Margin
-16.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $57M | -20.2% |
| FY2024 (proj) | $61M | -23.7% |
| FY2025 (proj) | $65M | -27.1% |